Barbara Barbé
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Barbara Barbé has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
- Jan Jacobs
Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium
8 shared publications - Philippe Gillet
Institute of Tropical Medicine, Antwerp, Belgium
6 shared publications Jan Jacobs
Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
4 shared publications- Liselotte Hardy
Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
4 shared publications - Emmanuel Bottieau
Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
3 shared publications - Jean-Roger Lilo Kalo
Institut National de Recherche Biomédicale, Av. De la Démocratie N°5345, 1197 Kinshasa, Democratic Republic of the Congo
3 shared publications
Latest Publications
- Open Access
- 22 January 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Performance evaluation of the BactInsight simplified blood culture system developed for resource-limited settings using a simulated test design
BactInsight is a simplified blood culture system designed for resource-limited settings. It consists of in-house produced blood culture bottles and a turbidimeter to detect microbial growth on top of visual inspection of blood culture bottles. A first proof-of-concept using simulated commercial blood cultures showed that the turbidimeter was able to detect growth in nine out of ten tested microbial species (i.e. by growth detection through turbidity and a colour indicator), however detection of turbidity was only successful in four of these species. In this study, we extended the in vitro testing to 20 microbial species spiked in fresh human blood and we used a second-generation turbidimeter prototype and in-house produced blood culture bottles. The BactInsight system’s performance was acceptable when compared with the automated BACT/ALERT system (bioMérieux). Moreover, the addition of the turbidimeter to visual inspection decreased the time-to-positivity for some microorganism groups. The system is cheap (~ 50 USD), robust and able to withstand high temperature and humidity. In conclusion, the BactInsight system has the potential to improve access to blood cultures in resource-limited settings.
- 22 January 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessPerformance evaluation of the BactInsight simplified blood culture system developed for resource-limited settings using a simulated test design
BactInsight is a simplified blood culture system designed for resource-limited settings. It consists of in-house produced blood culture bottles and a turbidimeter to detect microbial growth on top of visual inspection of blood culture bottles. A first proof-of-concept using simulated commercial blood cultures showed that the turbidimeter was able to detect growth in nine out of ten tested microbial species (i.e. by growth detection through turbidity and a colour indicator), however detection of turbidity was only successful in four of these species. In this study, we extended the in vitro testing to 20 microbial species spiked in fresh human blood and we used a second-generation turbidimeter prototype and in-house produced blood culture bottles. The BactInsight system’s performance was acceptable when compared with the automated BACT/ALERT system (bioMérieux). Moreover, the addition of the turbidimeter to visual inspection decreased the time-to-positivity for some microorganism groups. The system is cheap (~ 50 USD), robust and able to withstand high temperature and humidity. In conclusion, the BactInsight system has the potential to improve access to blood cultures in resource-limited settings.
- Open Access
- 1 January 2024
- Published by Wiley in International Journal of Biomedical Imaging
- Vol. 2024 (1)
Simple Imaging System for Label‐Free Identification of Bacterial Pathogens in Resource‐Limited Settings
Fast, accurate, and affordable bacterial identification methods are paramount for the timely treatment of infections, especially in resource‐limited settings (RLS). However, today, only 1.3% of the sub‐Saharan African diagnostic laboratories are performing clinical bacteriology. To improve this, diagnostic tools for RLS should prioritize simplicity, affordability, and ease of maintenance, as opposed to the costly equipment utilized for bacterial identification in high‐income countries, such as matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry (MALDI‐TOF MS). In this work, we present a new high‐throughput approach based on a simple wide‐field (864 mm2) lensless imaging system allowing for the acquisition of a large portion of a Petri dish coupled with a supervised deep learning algorithm for identification at the bacterial colony scale. This wide‐field imaging system is particularly well suited to RLS since it includes neither moving mechanical parts nor optics. We validated this approach through the acquisition and the subsequent analysis of a dataset comprising 252 clinical isolates from five species, encompassing some of the most prevalent pathogens. The resulting optical morphotypes exhibited intra‐ and interspecies variability, a scenario considerably more akin to real‐world clinical practice than the one achievable by solely concentrating on reference strains. Despite this variability, high identification performance was achieved with a correct species identification rate of 91.7%. These results open up some new prospects for identification in RLS. We released both the acquired dataset and the trained identification algorithm in publicly available repositories.
- 1 January 2024
- Published by Wiley in International Journal of Biomedical Imaging
- Vol. 2024 (1)
Open AccessSimple Imaging System for Label‐Free Identification of Bacterial Pathogens in Resource‐Limited Settings
Fast, accurate, and affordable bacterial identification methods are paramount for the timely treatment of infections, especially in resource‐limited settings (RLS). However, today, only 1.3% of the sub‐Saharan African diagnostic laboratories are performing clinical bacteriology. To improve this, diagnostic tools for RLS should prioritize simplicity, affordability, and ease of maintenance, as opposed to the costly equipment utilized for bacterial identification in high‐income countries, such as matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry (MALDI‐TOF MS). In this work, we present a new high‐throughput approach based on a simple wide‐field (864 mm2) lensless imaging system allowing for the acquisition of a large portion of a Petri dish coupled with a supervised deep learning algorithm for identification at the bacterial colony scale. This wide‐field imaging system is particularly well suited to RLS since it includes neither moving mechanical parts nor optics. We validated this approach through the acquisition and the subsequent analysis of a dataset comprising 252 clinical isolates from five species, encompassing some of the most prevalent pathogens. The resulting optical morphotypes exhibited intra‐ and interspecies variability, a scenario considerably more akin to real‐world clinical practice than the one achievable by solely concentrating on reference strains. Despite this variability, high identification performance was achieved with a correct species identification rate of 91.7%. These results open up some new prospects for identification in RLS. We released both the acquired dataset and the trained identification algorithm in publicly available repositories.
- Open Access
Mild and moderate COVID-19 during Alpha, Delta and Omikron pandemic waves in urban Maputo, Mozambique, December 2020-March 2022: a population-based surveillance study
In sub-Saharan Africa, reported COVID-19 numbers have been lower than anticipated, even when considering populations’ younger age. The extent to which risk factors, established in industrialised countries, impact the risk of infection and of disease in populations in sub-Saharan Africa, remains unclear. We estimated the incidence of mild and moderate COVID-19 in urban Mozambique and analysed factors associated with infection and disease in a population-based surveillance study. During December 2020-March 2022, households of a population cohort in Polana Caniço, Maputo, Mozambique, were contacted biweekly. Residents reporting any respiratory sign, anosmia, or ageusia, were asked to self-administer a nasal swab, for SARS-CoV-2 PCR testing. Of a subset of 1400 participants, dried blood spots were repeatedly collected three-monthly from finger pricks at home. Antibodies against SARS-CoV-2 spike glycoprotein and nucleocapsid protein were detected using an in-house developed multiplex antibody assay. We estimated the incidence of respiratory illness and COVID-19, and SARS-CoV-2 seroprevalence. We used Cox regression models, adjusting for age and sex, to identify factors associated with first symptomatic COVID-19 and with SARS-CoV-2 sero-conversion in the first six months. During 11925 household visits in 1561 households, covering 6049 participants (median 21 years, 54.8% female, 7.3% disclosed HIV positive), 1895.9 person-years were followed up. Per 1000 person-years, 364.5 (95%CI 352.8-376.1) respiratory illness episodes of which 72.2 (95%CI 60.6-83.9) COVID-19 confirmed, were reported. Of 1412 participants, 2185 blood samples were tested (median 30.6 years, 55.2% female). Sero-prevalence rose from 4.8% (95%CI 1.1-8.6%) in December 2020 to 34.7% (95%CI 20.2-49.3%) in June 2021, when 3.0% were vaccinated. Increasing age (strong gradient in hazard ratio, HR, up to 15.70 in ≥70 year olds, 95%CI 3.74-65.97), leukaemia, chronic lung disease, hypertension, and overweight increased risk of COVID-19. We found no increased risk of COVID-19 in people with HIV or tuberculosis. Risk of COVID-19 was lower among residents in the lowest socio-economic quintile (HR 0.16, 95%CI 0.04-0.64), with no or limited handwashing facilities, and who shared bedrooms (HR 0.42, 95%CI 0.25-0.72). Older age also increased the risk of SARS-CoV-2 seroconversion (HR 1.57 in 60-69 year olds, 95%CI 1.03-2.39). We found no associations between SARS-CoV-2 infection risk and socio-economic, behavioural factors and comorbidities. Active surveillance in an urban population cohort confirmed frequent COVID-19 underreporting, yet indicated that the large majority of cases were mild and non-febrile. In contrast to industrialised countries, deprivation did not increase the risk of infection nor disease.
Open AccessMild and moderate COVID-19 during Alpha, Delta and Omikron pandemic waves in urban Maputo, Mozambique, December 2020-March 2022: a population-based surveillance study
In sub-Saharan Africa, reported COVID-19 numbers have been lower than anticipated, even when considering populations’ younger age. The extent to which risk factors, established in industrialised countries, impact the risk of infection and of disease in populations in sub-Saharan Africa, remains unclear. We estimated the incidence of mild and moderate COVID-19 in urban Mozambique and analysed factors associated with infection and disease in a population-based surveillance study. During December 2020-March 2022, households of a population cohort in Polana Caniço, Maputo, Mozambique, were contacted biweekly. Residents reporting any respiratory sign, anosmia, or ageusia, were asked to self-administer a nasal swab, for SARS-CoV-2 PCR testing. Of a subset of 1400 participants, dried blood spots were repeatedly collected three-monthly from finger pricks at home. Antibodies against SARS-CoV-2 spike glycoprotein and nucleocapsid protein were detected using an in-house developed multiplex antibody assay. We estimated the incidence of respiratory illness and COVID-19, and SARS-CoV-2 seroprevalence. We used Cox regression models, adjusting for age and sex, to identify factors associated with first symptomatic COVID-19 and with SARS-CoV-2 sero-conversion in the first six months. During 11925 household visits in 1561 households, covering 6049 participants (median 21 years, 54.8% female, 7.3% disclosed HIV positive), 1895.9 person-years were followed up. Per 1000 person-years, 364.5 (95%CI 352.8-376.1) respiratory illness episodes of which 72.2 (95%CI 60.6-83.9) COVID-19 confirmed, were reported. Of 1412 participants, 2185 blood samples were tested (median 30.6 years, 55.2% female). Sero-prevalence rose from 4.8% (95%CI 1.1-8.6%) in December 2020 to 34.7% (95%CI 20.2-49.3%) in June 2021, when 3.0% were vaccinated. Increasing age (strong gradient in hazard ratio, HR, up to 15.70 in ≥70 year olds, 95%CI 3.74-65.97), leukaemia, chronic lung disease, hypertension, and overweight increased risk of COVID-19. We found no increased risk of COVID-19 in people with HIV or tuberculosis. Risk of COVID-19 was lower among residents in the lowest socio-economic quintile (HR 0.16, 95%CI 0.04-0.64), with no or limited handwashing facilities, and who shared bedrooms (HR 0.42, 95%CI 0.25-0.72). Older age also increased the risk of SARS-CoV-2 seroconversion (HR 1.57 in 60-69 year olds, 95%CI 1.03-2.39). We found no associations between SARS-CoV-2 infection risk and socio-economic, behavioural factors and comorbidities. Active surveillance in an urban population cohort confirmed frequent COVID-19 underreporting, yet indicated that the large majority of cases were mild and non-febrile. In contrast to industrialised countries, deprivation did not increase the risk of infection nor disease.
- Open Access
- 17 December 2023
- Published by BMJ in BMJ Global Health
- Vol. 8 (Suppl 10) , A75.2-A76
PA-394 Access to diagnosis of bloodstream infections in low-resource settings: evaluation of the improved “Turbidimeter” prototype to detect bacterial growth in manual blood culture systems
Background In low-resource settings, blood culture bottles (BCBs) are often visually inspected for signs of growth. We developed a “Turbidimeter” to objectively assess growth based on the presence of broth turbidity. The first generation Turbidimeter detected growth in four out of ten bacterial species (i.e. three Enterobacterales and one Streptococcus sp.) in simulated blood cultures inoculated with spiked horse blood. Here, we present the results of the second generation Turbidimeter. Methods Home-made BCBs (30 ml Tryptone Soy Broth with 0.3 mg/ml sodium-polyanethole sulphate) were inoculated with 2 ml of fresh human blood spiked with 20 different microorganisms (i.e. five Enterobacterales, three non-fermenting Gram-negative bacteria, two staphylococci, one Enterococcus sp., four streptococci, two fastidious organisms and three yeast spp). The BCBs were incubated in Turbidimeter modules inside a conventional incubator for 20–96 hours; measurements were done every 30 seconds. Growth detection was based on the decrease of transmitted and increase of scattered light. We compared growth detection between the first and second turbidimeter generation (improved design with new LED and detector). Results Growth was detected in 80% of 118 BCBs tested, showing full detection of all enterococci, streptococci, and non-fermenting Gram-negative bacteria (100%), and partial detection of Enterobacterales (84%), staphylococci (88%), fastidious organisms (17%) and yeast (67%). Compared with the first prototype, growth detection improved considerably. Six microorganisms that remained undetected before, were now (partially) detected: 100% growth detection of BCBs with Staphylococcus aureus, Burkholderia cepacia and Pseudomonas aeruginosa and 17% of BCBs with Candida albicans, Haemophilus influenzae and Neisseria subflava. Conclusion The second generation Turbidimeter showed improved growth detection (17–100% of BCBs) compared with the first prototype. Field testing will be conducted within the EDCTP2-funded SIMBLE project from May 2023 until end of 2024 in Benin and Burkina Faso, to evaluate performance and ease-of-use for future implementation in field laboratories.
- 17 December 2023
- Published by BMJ in BMJ Global Health
- Vol. 8 (Suppl 10) , A75.2-A76
Open AccessPA-394 Access to diagnosis of bloodstream infections in low-resource settings: evaluation of the improved “Turbidimeter” prototype to detect bacterial growth in manual blood culture systems
Background In low-resource settings, blood culture bottles (BCBs) are often visually inspected for signs of growth. We developed a “Turbidimeter” to objectively assess growth based on the presence of broth turbidity. The first generation Turbidimeter detected growth in four out of ten bacterial species (i.e. three Enterobacterales and one Streptococcus sp.) in simulated blood cultures inoculated with spiked horse blood. Here, we present the results of the second generation Turbidimeter. Methods Home-made BCBs (30 ml Tryptone Soy Broth with 0.3 mg/ml sodium-polyanethole sulphate) were inoculated with 2 ml of fresh human blood spiked with 20 different microorganisms (i.e. five Enterobacterales, three non-fermenting Gram-negative bacteria, two staphylococci, one Enterococcus sp., four streptococci, two fastidious organisms and three yeast spp). The BCBs were incubated in Turbidimeter modules inside a conventional incubator for 20–96 hours; measurements were done every 30 seconds. Growth detection was based on the decrease of transmitted and increase of scattered light. We compared growth detection between the first and second turbidimeter generation (improved design with new LED and detector). Results Growth was detected in 80% of 118 BCBs tested, showing full detection of all enterococci, streptococci, and non-fermenting Gram-negative bacteria (100%), and partial detection of Enterobacterales (84%), staphylococci (88%), fastidious organisms (17%) and yeast (67%). Compared with the first prototype, growth detection improved considerably. Six microorganisms that remained undetected before, were now (partially) detected: 100% growth detection of BCBs with Staphylococcus aureus, Burkholderia cepacia and Pseudomonas aeruginosa and 17% of BCBs with Candida albicans, Haemophilus influenzae and Neisseria subflava. Conclusion The second generation Turbidimeter showed improved growth detection (17–100% of BCBs) compared with the first prototype. Field testing will be conducted within the EDCTP2-funded SIMBLE project from May 2023 until end of 2024 in Benin and Burkina Faso, to evaluate performance and ease-of-use for future implementation in field laboratories.
- Open Access
- 23 October 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-17
A genomic appraisal of invasive Salmonella Typhimurium and associated antibiotic resistance in sub-Saharan Africa
Invasive non-typhoidal Salmonella (iNTS) disease manifesting as bloodstream infection with high mortality is responsible for a huge public health burden in sub-Saharan Africa. Salmonella enterica serovar Typhimurium (S. Typhimurium) is the main cause of iNTS disease in Africa. By analysing whole genome sequence data from 1303 S. Typhimurium isolates originating from 19 African countries and isolated between 1979 and 2017, here we show a thorough scaled appraisal of the population structure of iNTS disease caused by S. Typhimurium across many of Africa’s most impacted countries. At least six invasive S. Typhimurium clades have already emerged, with ST313 lineage 2 or ST313-L2 driving the current pandemic. ST313-L2 likely emerged in the Democratic Republic of Congo around 1980 and further spread in the mid 1990s. We observed plasmid-borne as well as chromosomally encoded fluoroquinolone resistance underlying emergences of extensive-drug and pan-drug resistance. Our work provides an overview of the evolution of invasive S. Typhimurium disease, and can be exploited to target control measures.
- 23 October 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-17
Open AccessA genomic appraisal of invasive Salmonella Typhimurium and associated antibiotic resistance in sub-Saharan Africa
Invasive non-typhoidal Salmonella (iNTS) disease manifesting as bloodstream infection with high mortality is responsible for a huge public health burden in sub-Saharan Africa. Salmonella enterica serovar Typhimurium (S. Typhimurium) is the main cause of iNTS disease in Africa. By analysing whole genome sequence data from 1303 S. Typhimurium isolates originating from 19 African countries and isolated between 1979 and 2017, here we show a thorough scaled appraisal of the population structure of iNTS disease caused by S. Typhimurium across many of Africa’s most impacted countries. At least six invasive S. Typhimurium clades have already emerged, with ST313 lineage 2 or ST313-L2 driving the current pandemic. ST313-L2 likely emerged in the Democratic Republic of Congo around 1980 and further spread in the mid 1990s. We observed plasmid-borne as well as chromosomally encoded fluoroquinolone resistance underlying emergences of extensive-drug and pan-drug resistance. Our work provides an overview of the evolution of invasive S. Typhimurium disease, and can be exploited to target control measures.
- Open Access
- 1 March 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (3) , 615
Pilot Testing of the “Turbidimeter”, a Simple, Universal Reader Intended to Complement and Enhance Bacterial Growth Detection in Manual Blood Culture Systems in Low-Resource Settings
Bloodstream infections and antimicrobial resistance are an increasing problem in low-income countries. There is a clear need for adapted diagnostic tools. To address this need, we developed a simple, universal reader prototype that detects bacterial growth in blood culture bottles. Our “turbidimeter” evaluates bacterial growth, based on the turbidity of the broth and the color change of the colorimetric CO2 indicator in commercially available blood culture bottles. A total of 60 measurements were performed using 10 relevant microbial species, spiked in horse blood, to compare the turbidimeter’s performance with that of an automatic reference system. The turbidimeter was able to detect growth in all but one of the spiked blood culture bottles. In the majority (7/10) of the species tested, time-to-detection of the turbidimeter was shown to be non-inferior to the reference automated time-to-detection. This was, however, only the case when both the turbidity and color change in the colorimetric CO2-indicator were used to evaluate growth. We could not demonstrate the non-inferiority of the turbidity measurement alone. Overall, the turbidimeter performed well, but we also identified some improvements that will be implemented in the next version of the prototype.
- 1 March 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (3) , 615
Open AccessPilot Testing of the “Turbidimeter”, a Simple, Universal Reader Intended to Complement and Enhance Bacterial Growth Detection in Manual Blood Culture Systems in Low-Resource Settings
Bloodstream infections and antimicrobial resistance are an increasing problem in low-income countries. There is a clear need for adapted diagnostic tools. To address this need, we developed a simple, universal reader prototype that detects bacterial growth in blood culture bottles. Our “turbidimeter” evaluates bacterial growth, based on the turbidity of the broth and the color change of the colorimetric CO2 indicator in commercially available blood culture bottles. A total of 60 measurements were performed using 10 relevant microbial species, spiked in horse blood, to compare the turbidimeter’s performance with that of an automatic reference system. The turbidimeter was able to detect growth in all but one of the spiked blood culture bottles. In the majority (7/10) of the species tested, time-to-detection of the turbidimeter was shown to be non-inferior to the reference automated time-to-detection. This was, however, only the case when both the turbidity and color change in the colorimetric CO2-indicator were used to evaluate growth. We could not demonstrate the non-inferiority of the turbidity measurement alone. Overall, the turbidimeter performed well, but we also identified some improvements that will be implemented in the next version of the prototype.
- Open Access
- 1 October 2021
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 27 (10) , 1400-1408
Culture media for clinical bacteriology in low- and middle-income countries: challenges, best practices for preparation and recommendations for improved access
- 1 October 2021
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 27 (10) , 1400-1408
Open AccessCulture media for clinical bacteriology in low- and middle-income countries: challenges, best practices for preparation and recommendations for improved access
- Open Access
Onchocerciasis Prevalence among Persons with Epilepsy in an Onchocerciasis Hypo-Endemic Area in the Democratic Republic of Congo: A Cross-Sectional Study
A high epilepsy prevalence has been reported in onchocerciasis meso- and hyper-endemic regions in sub-Saharan Africa, including in the Democratic Republic of Congo (DRC). We investigated whether onchocerciasis-associated epilepsy can also be suspected in onchocerciasis hypo-endemic regions. Stored serum samples from 342 patients admitted with recent onset neurological symptoms admitted to Mosango general hospital, in the Kwilu province, DRC, between 2012 and 2015 were screened for onchocerciasis (OV16) antibodies by ELISA and Taenia solium antigen (using an in-house B158/B60 antigen test). Eighty-one (23.7%; 95% CI 19.5–28.5%) of these samples were positive for OV16 antibodies and 43/340 (12.6%; 95% CI 9.5–16.6%) were positive for T. solium antigen. Of the 58 persons clinically diagnosed with late onset epilepsy of unknown etiology, 19 (32.8%) were OV16 positive and nine (16%) T. solium antigen positive. In total, 16 persons with epilepsy were OV16 positive and T. solium negative, of whom 12 (75%) were between the ages seven to 31 years old, an age rage in which onchocerciasis-associated epilepsy is observed. Our study suggests that in onchocerciasis hypo-endemic areas, in T. solium antigen negative persons with epilepsy, onchocerciasis should be considered as a potential trigger of epilepsy.
Open AccessOnchocerciasis Prevalence among Persons with Epilepsy in an Onchocerciasis Hypo-Endemic Area in the Democratic Republic of Congo: A Cross-Sectional Study
A high epilepsy prevalence has been reported in onchocerciasis meso- and hyper-endemic regions in sub-Saharan Africa, including in the Democratic Republic of Congo (DRC). We investigated whether onchocerciasis-associated epilepsy can also be suspected in onchocerciasis hypo-endemic regions. Stored serum samples from 342 patients admitted with recent onset neurological symptoms admitted to Mosango general hospital, in the Kwilu province, DRC, between 2012 and 2015 were screened for onchocerciasis (OV16) antibodies by ELISA and Taenia solium antigen (using an in-house B158/B60 antigen test). Eighty-one (23.7%; 95% CI 19.5–28.5%) of these samples were positive for OV16 antibodies and 43/340 (12.6%; 95% CI 9.5–16.6%) were positive for T. solium antigen. Of the 58 persons clinically diagnosed with late onset epilepsy of unknown etiology, 19 (32.8%) were OV16 positive and nine (16%) T. solium antigen positive. In total, 16 persons with epilepsy were OV16 positive and T. solium negative, of whom 12 (75%) were between the ages seven to 31 years old, an age rage in which onchocerciasis-associated epilepsy is observed. Our study suggests that in onchocerciasis hypo-endemic areas, in T. solium antigen negative persons with epilepsy, onchocerciasis should be considered as a potential trigger of epilepsy.
- Open Access
- 2 July 2020
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 14 (7) , e0008377
High genetic similarity between non-typhoidal Salmonella isolated from paired blood and stool samples of children in the Democratic Republic of the Congo
Non-typhoidal Salmonella (NTS) serotypes Typhimurium and Enteritidis are a major cause of bloodstream infections in children in sub-Saharan Africa but their reservoir is unknown. We compared pairs of NTS blood and stool isolates (with the same NTS serotype recovered in the same patient) for genetic similarity. Between November 2013 and April 2017, hospital-admitted children (29 days to 14 years) with culture-confirmed NTS bloodstream infections were enrolled in a cross-sectional study at Kisantu Hospital, DR Congo. Stool cultures for Salmonella were performed on a subset of enrolled children, as well as on a control group of non-febrile hospital-admitted children. Pairs of blood and stool NTS isolates were assessed for genetic similarity by multiple-locus variable-number of tandem repeats (MLVA) and genomics analysis. A total of 299 children with NTS grown from blood cultures (Typhimurium 68.6%, Enteritidis 30.4%, other NTS 1.0%) had a stool sample processed; in 105 (35.1%) of them NTS was detected (Typhimurium 70.5%, Enteritidis 25.7%, other NTS 3.8%). A total of 87/105 (82.9%) pairs of blood and stool NTS isolates were observed (representing 29.1% of the 299 children). Among 1598 controls, the proportion of NTS stool excretion was 2.1% (p < 0.0001). MLVA types among paired isolates were identical in 82/87 (94.3%) pairs (27.4% of the 299 children; 61/66 (92.4%) in Typhimurium and 21/21 (100%) in Enteritidis pairs). Genomics analysis confirmed high genetic similarity within 41/43 (95.3%) pairs, showing a median SNP difference of 1 (range 0–77) and 1 (range 0–4) for Typhimurium and Enteritidis pairs respectively. Typhimurium and Enteritidis isolates belonged to sequence types ST313 lineage II and ST11 respectively. Nearly 30% of children with NTS bloodstream infection showed stool excretion of an NTS isolate with high genetic similarity, adding to the evidence of humans as a potential reservoir for NTS. Non-typhoidal Salmonella (NTS) is an important cause of bloodstream infections in sub-Saharan Africa, but little is known about its reservoir and transmission. We assessed the possibility of a human reservoir by culturing stool samples from children with NTS found in their blood. Next, we compared the obtained blood and stool NTS isolates for genetic similarity. We found that a high proportion of children with NTS in their blood also had NTS in their stool (35.1%) when compared to a control group of children without suspicion of bloodstream infection (2.1%). We observed that Salmonella Typhimurium and Salmonella Enteritidis were the main serotypes isolated from blood and stool, and that their proportions were similar within the different populations. We found that 94.3% of the paired NTS blood and stool isolates (or 27.4% of children with NTS in their blood and a stool culture done) were genetically similar to each other. This observation adds to the evidence of a potential human reservoir for NTS.
- 2 July 2020
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 14 (7) , e0008377
Open AccessHigh genetic similarity between non-typhoidal Salmonella isolated from paired blood and stool samples of children in the Democratic Republic of the Congo
Non-typhoidal Salmonella (NTS) serotypes Typhimurium and Enteritidis are a major cause of bloodstream infections in children in sub-Saharan Africa but their reservoir is unknown. We compared pairs of NTS blood and stool isolates (with the same NTS serotype recovered in the same patient) for genetic similarity. Between November 2013 and April 2017, hospital-admitted children (29 days to 14 years) with culture-confirmed NTS bloodstream infections were enrolled in a cross-sectional study at Kisantu Hospital, DR Congo. Stool cultures for Salmonella were performed on a subset of enrolled children, as well as on a control group of non-febrile hospital-admitted children. Pairs of blood and stool NTS isolates were assessed for genetic similarity by multiple-locus variable-number of tandem repeats (MLVA) and genomics analysis. A total of 299 children with NTS grown from blood cultures (Typhimurium 68.6%, Enteritidis 30.4%, other NTS 1.0%) had a stool sample processed; in 105 (35.1%) of them NTS was detected (Typhimurium 70.5%, Enteritidis 25.7%, other NTS 3.8%). A total of 87/105 (82.9%) pairs of blood and stool NTS isolates were observed (representing 29.1% of the 299 children). Among 1598 controls, the proportion of NTS stool excretion was 2.1% (p < 0.0001). MLVA types among paired isolates were identical in 82/87 (94.3%) pairs (27.4% of the 299 children; 61/66 (92.4%) in Typhimurium and 21/21 (100%) in Enteritidis pairs). Genomics analysis confirmed high genetic similarity within 41/43 (95.3%) pairs, showing a median SNP difference of 1 (range 0–77) and 1 (range 0–4) for Typhimurium and Enteritidis pairs respectively. Typhimurium and Enteritidis isolates belonged to sequence types ST313 lineage II and ST11 respectively. Nearly 30% of children with NTS bloodstream infection showed stool excretion of an NTS isolate with high genetic similarity, adding to the evidence of humans as a potential reservoir for NTS. Non-typhoidal Salmonella (NTS) is an important cause of bloodstream infections in sub-Saharan Africa, but little is known about its reservoir and transmission. We assessed the possibility of a human reservoir by culturing stool samples from children with NTS found in their blood. Next, we compared the obtained blood and stool NTS isolates for genetic similarity. We found that a high proportion of children with NTS in their blood also had NTS in their stool (35.1%) when compared to a control group of children without suspicion of bloodstream infection (2.1%). We observed that Salmonella Typhimurium and Salmonella Enteritidis were the main serotypes isolated from blood and stool, and that their proportions were similar within the different populations. We found that 94.3% of the paired NTS blood and stool isolates (or 27.4% of children with NTS in their blood and a stool culture done) were genetically similar to each other. This observation adds to the evidence of a potential human reservoir for NTS.
- Open Access
- 1 January 2018
- Published by Elsevier in EBioMedicine
- Vol. 27, 11-17
A Phase III Diagnostic Accuracy Study of a Rapid Diagnostic Test for Diagnosis of Second-Stage Human African Trypanosomiasis in the Democratic Republic of the Congo
- 1 January 2018
- Published by Elsevier in EBioMedicine
- Vol. 27, 11-17
Open AccessA Phase III Diagnostic Accuracy Study of a Rapid Diagnostic Test for Diagnosis of Second-Stage Human African Trypanosomiasis in the Democratic Republic of the Congo